| A consensus molecular classification of muscle-invasive bladder cancer A Kamoun, A de Reynies, Y Allory, G Sjödahl, AG Robertson, R Seiler, ... European urology 77 (4), 420-433, 2020 | 1073 | 2020 |
| International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer MI Canto, F Harinck, RH Hruban, GJ Offerhaus, JW Poley, I Kamel, Y Nio, ... Gut 62 (3), 339-347, 2013 | 872 | 2013 |
| NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses M García-Closas, N Malats, D Silverman, M Dosemeci, M Kogevinas, ... The Lancet 366 (9486), 649-659, 2005 | 786 | 2005 |
| Bladder cancer and exposure to water disinfection by-products through ingestion, bathing, showering, and swimming in pools CM Villanueva, KP Cantor, JO Grimalt, N Malats, D Silverman, A Tardon, ... American journal of epidemiology 165 (2), 148-156, 2007 | 737 | 2007 |
| Detectable clonal mosaicism and its relationship to aging and cancer KB Jacobs, M Yeager, W Zhou, S Wacholder, Z Wang, ... Nature genetics 44 (6), 651-658, 2012 | 682 | 2012 |
| Comprehensive transcriptional analysis of early-stage urothelial carcinoma J Hedegaard, P Lamy, I Nordentoft, F Algaba, S Høyer, BP Ulhøi, S Vang, ... Cancer cell 30 (1), 27-42, 2016 | 621 | 2016 |
| Addressing the challenges of pancreatic cancer: future directions for improving outcomes M Hidalgo, S Cascinu, J Kleeff, R Labianca, JM Löhr, J Neoptolemos, ... Pancreatology 15 (1), 8-18, 2015 | 620 | 2015 |
| A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns F Notta, M Chan-Seng-Yue, M Lemire, Y Li, GW Wilson, AA Connor, ... Nature 538 (7625), 378-382, 2016 | 588 | 2016 |
| A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci N Rothman, M Garcia-Closas, N Chatterjee, N Malats, X Wu, JD Figueroa, ... Nature genetics 42 (11), 978-984, 2010 | 522 | 2010 |
| Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. F Graus, J Dalmou, R Rene, M Tora, N Malats, JJ Verschuuren, ... Journal of Clinical Oncology 15 (8), 2866-2872, 1997 | 462 | 1997 |
| Genetic profile of 22 pancreatic carcinoma cell lines: Analysis of K-ras, p53, p16 and DPC4/Smad4 PS Moore, B Sipos, S Orlandini, C Sorio, FX Real, NR Lemoine, T Gress, ... Virchows Archiv 439, 798-802, 2001 | 451 | 2001 |
| Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma SE Krown, FX Real, S Cunningham-Rundles, PL Myskowski, B Koziner, ... New England Journal of Medicine 308 (18), 1071-1076, 1983 | 445 | 1983 |
| Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage M Porta, X Fabregat, N Malats, L Guarner, A Carrato, A De Miguel, L Ruiz, ... Clinical and Translational Oncology 7, 189-197, 2005 | 422 | 2005 |
| Prospective Study of FGFR3 Mutations As a Prognostic Factor in Nonmuscle Invasive Urothelial Bladder Carcinomas S Hernández, E López-Knowles, J Lloreta, M Kogevinas, A Amorós, ... Journal of Clinical Oncology 24 (22), 3664-3671, 2006 | 411 | 2006 |
| P53 as a prognostic marker for bladder cancer: a meta-analysis and review N Malats, A Bustos, CM Nascimento, F Fernandez, M Rivas, D Puente, ... The lancet oncology 6 (9), 678-686, 2005 | 382 | 2005 |
| Epidemiology of urinary bladder cancer: from tumor development to patient’s death C Murta-Nascimento, BJ Schmitz-Dräger, MP Zeegers, G Steineck, ... World journal of urology 25, 285-295, 2007 | 366 | 2007 |
| Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma CR Divgi, S Welt, M Kris, FX Real, SDJ Yeh, R Gralla, B Merchant, ... JNCI: Journal of the National Cancer Institute 83 (2), 97-104, 1991 | 360 | 1991 |
| Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer BM Wolpin, C Rizzato, P Kraft, C Kooperberg, GM Petersen, Z Wang, ... Nature genetics 46 (9), 994-1000, 2014 | 355 | 2014 |
| Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome L Groesser, E Herschberger, A Ruetten, C Ruivenkamp, E Lopriore, ... Nature genetics 44 (7), 783-787, 2012 | 329 | 2012 |
| Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy C Balbás-Martínez, A Sagrera, E Carrillo-de-Santa-Pau, J Earl, ... Nature genetics 45 (12), 1464-1469, 2013 | 328 | 2013 |
